131 related articles for article (PubMed ID: 31456475)
1. Polyethylenimine and sodium cholate-modified ethosomes complex as multidrug carriers for the treatment of melanoma through transdermal delivery.
Ma L; Wang X; Wu J; Zhang D; Zhang L; Song X; Hong H; He C; Mo X; Wu S; Kai G; Wang H
Nanomedicine (Lond); 2019 Sep; 14(18):2395-2408. PubMed ID: 31456475
[No Abstract] [Full Text] [Related]
2. Bioreducible poly(2-ethyl-2-oxazoline)-PLA-PEI-SS triblock copolymer micelles for co-delivery of DNA minicircles and Doxorubicin.
Gaspar VM; Baril P; Costa EC; de Melo-Diogo D; Foucher F; Queiroz JA; Sousa F; Pichon C; Correia IJ
J Control Release; 2015 Sep; 213():175-191. PubMed ID: 26184050
[TBL] [Abstract][Full Text] [Related]
3. Bovine serum albumin nanoparticles improve the antitumour activity of curcumin in a murine melanoma model.
Camargo LEA; Brustolin Ludwig D; Tominaga TT; Carletto B; Favero GM; Mainardes RM; Khalil NM
J Microencapsul; 2018 Aug; 35(5):467-474. PubMed ID: 30246573
[TBL] [Abstract][Full Text] [Related]
4. Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide.
Chen X; Wang X; Wang Y; Yang L; Hu J; Xiao W; Fu A; Cai L; Li X; Ye X; Liu Y; Wu W; Shao X; Mao Y; Wei Y; Chen L
J Control Release; 2010 Jul; 145(1):17-25. PubMed ID: 20307599
[TBL] [Abstract][Full Text] [Related]
5. Targeted delivery of RGD-modified liposomes encapsulating both combretastatin A-4 and doxorubicin for tumor therapy: in vitro and in vivo studies.
Zhang YF; Wang JC; Bian DY; Zhang X; Zhang Q
Eur J Pharm Biopharm; 2010 Mar; 74(3):467-73. PubMed ID: 20064608
[TBL] [Abstract][Full Text] [Related]
6. In Vivo Antitumor Activity of Folate-Conjugated Cholic Acid-Polyethylenimine Micelles for the Codelivery of Doxorubicin and siRNA to Colorectal Adenocarcinomas.
Amjad MW; Amin MC; Katas H; Butt AM; Kesharwani P; Iyer AK
Mol Pharm; 2015 Dec; 12(12):4247-58. PubMed ID: 26567518
[TBL] [Abstract][Full Text] [Related]
7. Improved anti-melanoma effect of a transdermal mitoxantrone ethosome gel.
Yu X; Du L; Li Y; Fu G; Jin Y
Biomed Pharmacother; 2015 Jul; 73():6-11. PubMed ID: 26211575
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticle assisted solvent selective transdermal combination therapy of curcumin and 5-flurouracil for efficient cancer treatment.
Anirudhan TS; Nair AS; Bino SJ
Carbohydr Polym; 2017 Oct; 173():131-142. PubMed ID: 28732851
[TBL] [Abstract][Full Text] [Related]
9. Curcumin loaded chitin nanogels for skin cancer treatment via the transdermal route.
Mangalathillam S; Rejinold NS; Nair A; Lakshmanan VK; Nair SV; Jayakumar R
Nanoscale; 2012 Jan; 4(1):239-50. PubMed ID: 22080352
[TBL] [Abstract][Full Text] [Related]
10. [Effects of penetration enhancers on curcumin transdermal drug delivery].
Gao ZS; Wang L; Zhang M
Zhong Yao Cai; 2012 Jan; 35(1):141-4. PubMed ID: 22734426
[TBL] [Abstract][Full Text] [Related]
11. Synergistically Improved Anti-tumor Efficacy by Co-delivery Doxorubicin and Curcumin Polymeric Micelles.
Wang J; Ma W; Tu P
Macromol Biosci; 2015 Sep; 15(9):1252-61. PubMed ID: 25981672
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary delivery by exploiting doxorubicin and cisplatin co-loaded nanoparticles for metastatic lung cancer therapy.
Xu C; Wang Y; Guo Z; Chen J; Lin L; Wu J; Tian H; Chen X
J Control Release; 2019 Feb; 295():153-163. PubMed ID: 30586598
[TBL] [Abstract][Full Text] [Related]
13. Nano-assemblies of J-aggregates based on a NIR dye as a multifunctional drug carrier for combination cancer therapy.
Song X; Zhang R; Liang C; Chen Q; Gong H; Liu Z
Biomaterials; 2015 Jul; 57():84-92. PubMed ID: 25913253
[TBL] [Abstract][Full Text] [Related]
14. Bypassing multidrug resistant ovarian cancer using ultrasound responsive doxorubicin/curcumin co-deliver alginate nanodroplets.
Baghbani F; Moztarzadeh F
Colloids Surf B Biointerfaces; 2017 May; 153():132-140. PubMed ID: 28235723
[TBL] [Abstract][Full Text] [Related]
15. Enhanced 4T1 breast carcinoma anticancer activity by co-delivery of doxorubicin and curcumin with core-shell drug-carrier based on heparin modified poly(L-lactide) grafted polyethylenimine cationic nanoparticles.
Guo O; Li X; Yang Y; Wei J; Zhao Q; Luo F; Qian Z
J Biomed Nanotechnol; 2014 Feb; 10(2):227-37. PubMed ID: 24738331
[TBL] [Abstract][Full Text] [Related]
16. Polyvinyl Alcohol/Hydroxyethylcellulose Containing Ethosomes as a Scaffold for Transdermal Drug Delivery Applications.
El Fawal G; Hong H; Song X; Wu J; Sun M; Zhang L; He C; Mo X; Wang H
Appl Biochem Biotechnol; 2020 Aug; 191(4):1624-1637. PubMed ID: 32198603
[TBL] [Abstract][Full Text] [Related]
17. Albumin nanoparticles with synergistic antitumor efficacy against metastatic lung cancers.
Kim B; Seo B; Park S; Lee C; Kim JO; Oh KT; Lee ES; Choi HG; Youn YS
Colloids Surf B Biointerfaces; 2017 Oct; 158():157-166. PubMed ID: 28688365
[TBL] [Abstract][Full Text] [Related]
18. Reversal of multidrug resistance in MCF-7/Adr cells by codelivery of doxorubicin and BCL2 siRNA using a folic acid-conjugated polyethylenimine hydroxypropyl-β-cyclodextrin nanocarrier.
Li JM; Zhang W; Su H; Wang YY; Tan CP; Ji LN; Mao ZW
Int J Nanomedicine; 2015; 10():3147-62. PubMed ID: 25960653
[TBL] [Abstract][Full Text] [Related]
19. Factorial design based curcumin ethosomal nanocarriers for the skin cancer delivery:
Peram MR; Jalalpure S; Kumbar V; Patil S; Joshi S; Bhat K; Diwan P
J Liposome Res; 2019 Sep; 29(3):291-311. PubMed ID: 30526186
[TBL] [Abstract][Full Text] [Related]
20. Co-delivery of anti-vascular endothelial growth factor siRNA and doxorubicin by multifunctional polymeric micelle for tumor growth suppression.
Huang HY; Kuo WT; Chou MJ; Huang YY
J Biomed Mater Res A; 2011 Jun; 97(3):330-8. PubMed ID: 21465641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
